Hetero Labs Profile
Key Indicators
- Authorised Capital ₹ 320.00 Cr
- Paid Up Capital ₹ 277.06 Cr
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5,716.35 Cr
- Satisfied Charges ₹ 13,849.42 Cr
- Revenue Growth 10.43%
- Profit Growth 10.80%
- Ebitda 21.70%
- Net Worth 12.37%
- Total Assets 10.59%
About Hetero Labs
Hetero Labs Limited (HLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 10 March 1989 and has a history of 35 years and 11 months. Its registered office is in Rangareddy, Telangana, India.
The Corporate was formerly known as Permila Drugs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 320.00 Cr and a paid-up capital of Rs 277.06 Cr.
The company currently has active open charges totaling ₹5,716.35 Cr. The company has closed loans amounting to ₹13,849.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hetero Labs Limited India are Sudershan Pallap as COMPANY SECRETARY and Bhavesh Pujara as Cfo. Bandi Vamsikrishna, Govindaraju Bhavani, Sujesh Vasudevan, and Five other members serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110TG1989PLC009723
- Company No.
009723
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
What products or services does Hetero Labs Limited offer?
Hetero Labs Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Remdesivir Injection, Anti Cancer Injection, Bevacizumab, Favipiravir Tablet, Favivir Tablet, Pain Reliever Gel, Combiflam Gel, Paracetamol Tablets, Combiflam Tablet.
Who are the key members and board of directors at Hetero Labs?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bandi Vamsikrishna  | Managing Director | 10-Apr-2008 | Current |
| Sudershan Pallap | Company Secretary | 01-Apr-2021 | Current |
| Bhavesh Pujara | CFO | 17-Nov-2022 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Govindaraju Bhavani | Director | 11-Aug-2023 | Current |
| Sujesh Vasudevan | Director | 22-Feb-2024 | Current |
| Rathnakar Kura | Director | 02-Jun-2014 | Current |
| Mohana Chilukuri | Whole-Time Director | 18-Nov-1999 | Current |
| Attunuri Reddy | Whole-Time Director | 02-Jun-2014 | Current |
| Srinivas Male | Director | 25-Sep-2008 | Current |
Financial Performance of Hetero Labs.
Hetero Labs Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.43% increase. The company also saw a substantial improvement in profitability, with a 10.8% increase in profit. The company's net worth Soared by an impressive increase of 12.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hetero Labs?
In 2023, Hetero Labs had a promoter holding of 100.00%. The company had 14 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hetero Marbles Private LimitedBandi Vamsikrishna and Srinivas Male are mutual person
Dasami Lab Private LimitedMohana Chilukuri is a mutual person
- Hetero Drugs Limited
Bandi Vamsikrishna, Rathnakar Kura and 2 more are mutual person
- Hetero Biopharma Limited
Bandi Vamsikrishna, Govindaraju Bhavani and 1 more are mutual person
- Hetero Wind Power Limited
Bandi Vamsikrishna is a mutual person
- Hetero Med Solutions Limited
Bandi Vamsikrishna is a mutual person
Charges (Loans)
Open Charges
₹5,716.35 Cr
Satisfied Charges
₹13,849.42 Cr
Charges Breakdown by Lending Institutions
- Idbi Trusteeship Services Limited : 4990.00 Cr
- State Bank Of India : 700.41 Cr
- Others : 24.94 Cr
- Hdfc Bank Limited : 0.76 Cr
- Axis Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2024 | Others | ₹1.50 M | Open |
| 13 Jul 2024 | Others | ₹1.48 M | Open |
| 28 Jun 2024 | Others | ₹0.90 M | Open |
| 12 May 2024 | Others | ₹2.00 M | Open |
| 30 Mar 2024 | Others | ₹0.70 M | Open |
How Many Employees Work at Hetero Labs?
Hetero Labs has a workforce of 7319 employees as of Nov 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hetero Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetero Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Hetero Labs
Recent activity within the organization
- Charges
A charge with Idbi Trusteeship Services Limited of Rs. 4,990.00 Cr registered on 21 Sep 2020 with Charge ID 100383489 was modified on 07 Nov 2024.
- Annual General Meeting
Hetero Labs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge registered on 31 Mar 2021 via Charge ID 100446079 with Hdfc Bank Limited was fully satisfied on 07 Aug 2024.
- Charges
A charge registered on 06 Mar 2021 via Charge ID 100437388 with Hdfc Bank Limited was fully satisfied on 07 Aug 2024.
- Charges
A charge registered on 03 Mar 2021 via Charge ID 100444242 with Hdfc Bank Limited was fully satisfied on 07 Aug 2024.
- Charges
A charge registered on 11 Feb 2021 via Charge ID 100421097 with Hdfc Bank Limited was fully satisfied on 07 Aug 2024.
Recent News, Updates & Announcement
Latest ARB Recall Triggered by New Impurity.Hetero Labs recalls losartan potassium tablets due to presence of N-Nitroso-N-methyl-4-aminobutyric acid..
- New cancer-causing toxin found in recalled blood pressure pills.
The U.S. Food and Drug Administration is also looking into whether these types of impurities could be found in other classes of drugs, a spokeswoman for the regulator said..
- Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API).
/PRNewswire/ -- Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted....
- Hetero launches generic breast cancer treatment drug in India.
Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country..
- Hetero Labs Limited acquires Tarbis Farma in Spain.
The acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio, manpower and a seamless entry into the Retail, Hospital and Tender business channels in Spain..
Frequently asked questions
What is the Incorporation or founding date of Hetero Labs Limited?
Hetero Labs Limited was incorporated on 10 Mar 1989.
What is authorized share capital and paid-up capital of Hetero Labs Limited?
The authorized share capital of Hetero Labs Limited is ₹ 320.00 Cr and paid-up capital is ₹ 277.06 Cr.
Who are the current board members & directors of Hetero Labs Limited?
Currently 10 directors are associated with Hetero Labs Limited.
- Bandi Vamsikrishna
- Govindaraju Bhavani
- Sudershan Pallap
- Bhavesh Bansidhar Pujara
- Sujesh Vasudevan
- Rathnakar Reddy Kura
- Mohana Reddy Chilukuri
- Attunuri Venkatanarasa Reddy
- Srinivas Reddy Male
- Parthasaradhi Reddy Bandi
What is the registered address of Hetero Labs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Hetero Labs Limited is 7-2-A2 Industrial Estate Sanath Nagar, India, Balanagar, Telangana, 500018.
What is the corporate identification number (CIN) and company number of Hetero Labs Limited?
The corporate identification number (CIN) of Hetero Labs Limited is U24110TG1989PLC009723 and the company number is 009723 as per Ministry of Corporate Affairs (MCA).
What is the official website of Hetero Labs Limited?
The Official website of Hetero Labs Limited is https://www.hetero.com
What has been the recent revenue trend for Hetero Labs Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Hetero Labs Limited has risen by 10.43%.
How many employees does Hetero Labs Limited currently have?
As Per 2023 financial reports, 7319 employees are currently employed by Hetero Labs Limited.
What change has been observed in the net worth of Hetero Labs Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Hetero Labs Limited has experienced an upsurge of 12.37%.
What are the total open charges for Hetero Labs Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Hetero Labs Limited amount to ₹ 5,716.35 Cr.
When was the last Balance Sheet of Hetero Labs Limited filed with the ROC?
The most recent Balance Sheet for Hetero Labs Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
GA
Gopal AnnareddyDirectorRR
Rajasekhara ReddyDirectorKB
Kalavathi BandiDirectorBN
Bollareddy NarasaDirector
Similar Companies Based on API Manufacturers
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India
Intas Pharmaceuticals Limited Ahmedabad, Gujarat, India